Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI to Target Cancer Deaths in the UK

By HospiMedica International staff writers
Posted on 31 May 2018
Theresa May, Prime Minister of the United Kingdom, is aiming to cut cancer deaths by 10% using artificial intelligence (AI) as the key driver of improved health outcomes.

The ambitious new plan calls for the National Health Service (NHS, London), the AI industrial sector, and health charities to use data and AI to transform the diagnosis of chronic diseases, with the goal of seeing around 22,000 fewer people dying from cancer each year by 2033. More...
The plans will see at least 50,000 people each year diagnosed at an early stage of prostate, ovarian, lung, or bowel cancer through the use of emerging technologies that will cross-reference people’s genetics, habits, and medical records with national data to spot those at an early stage of cancer.

“The development of smart technologies to analyze great quantities of data quickly and with a higher degree of accuracy than is possible by human beings opens up a whole new field of medical research, and gives us a new weapon in our armory in the fight against disease,” said Prime Minister May. “Achieving this mission will not only save thousands of lives; it will incubate a whole new industry around AI-in-healthcare, creating high-skilled science jobs across the country, drawing on existing centers of excellence in places like Edinburgh, Oxford, and Leeds, and helping to grow new ones.”

“Earlier detection and diagnosis could fundamentally transform outcomes for people with cancer, as well as saving the NHS money. The Government’s mission to revolutionize healthcare using the power of artificial intelligence is pioneering,” said Sir Harpal Kumar, CEO of Cancer Research (London, United Kingdom). “Advances in detection technologies depend on the intelligent use of data and have the potential to save hundreds of thousands of lives every year. We need to ensure we have the right infrastructure, embedded in our health system, to make this possible.”

“There is promising evidence that using artificial intelligence to analyze MRI scans could spot early signs of heart disease which may be missed by current techniques,” added Simon Gillespie, CEO of the British Heart Foundation (Birmingham, United Kingdom). “This could lead to a quicker diagnosis with more personalized treatment that could ultimately save lives.”

Most of the information in clinics and medical practices is stored digitally, but image data, findings, lab values, digital patient records, and surgery reports have all been handled separately. But current trends are encouraging data integration into one unified software framework that will enable faster handling of medical information, and will lay the foundation for more efficient interaction between different specialties and enable more precise and personalized clinical decisions.

Related Links:
National Health Service
Cancer Research
British Heart Foundation


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Desk Aneroid Sphyg
Diagnostix 750D+
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.